Activation of P38 MAPK Pathway in the Skull Abnormalities of Apert Syndrome Fgfr2(+P253R) Mice

Overview

Journal BMC Dev Biol

Publisher Biomed Central

Specialties Biology
Reproductive Medicine

Date 2010 Feb 24

PMID 20175913

Citations 53

Authors

Yingli Wang

Miao Sun

Victoria L Uhlhorn

Xueyan Zhou

Inga Peter

Neus Martinez-Abadias

Cheryl A Hill

Christopher J Percival

Joan T Richtsmeier

David L Huso

Ethylin Wang Jabs

Affiliations

Soon will be listed here.

Abstract

Background: Apert syndrome is characterized by craniosynostosis and limb abnormalities and is primarily caused by FGFR2 +/P253R and +/S252W mutations. The former mutation is present in approximately one third whereas the latter mutation is present in two-thirds of the patients with this condition. We previously reported an inbred transgenic mouse model with the Fgfr2 +/S252W mutation on the C57BL/6J background for Apert syndrome. Here we present a mouse model for the Fgfr2+/P253R mutation.

Results: We generated inbred Fgfr2(+/P253R) mice on the same C56BL/6J genetic background and analyzed their skeletal abnormalities. 3D micro-CT scans of the skulls of the Fgfr2(+/P253R) mice revealed that the skull length was shortened with the length of the anterior cranial base significantly shorter than that of the Fgfr2(+/S252W) mice at P0. The Fgfr2(+/P253R) mice presented with synostosis of the coronal suture and proximate fronts with disorganized cellularity in sagittal and lambdoid sutures. Abnormal osteogenesis and proliferation were observed at the developing coronal suture and long bones of the Fgfr2(+/P253R) mice as in the Fgfr2(+/S252W) mice. Activation of mitogen-activated protein kinases (MAPK) was observed in the Fgfr2(+/P253R) neurocranium with an increase in phosphorylated p38 as well as ERK1/2, whereas phosphorylated AKT and PKCalpha were not obviously changed as compared to those of wild-type controls. There were localized phenotypic and molecular variations among individual embryos with different mutations and among those with the same mutation.

Conclusions: Our in vivo studies demonstrated that the Fgfr2 +/P253R mutation resulted in mice with cranial features that resemble those of the Fgfr2(+/S252W) mice and human Apert syndrome. Activated p38 in addition to the ERK1/2 signaling pathways may mediate the mutant neurocranial phenotype. Though Apert syndrome is traditionally thought to be a consistent phenotype, our results suggest localized and regional variations in the phenotypes that characterize Apert syndrome.

Citing Articles

3D imaging reveals changes in the neurovascular architecture of the murine calvarium with aging.

Horenberg A, Ren Y, Zeng E, Rindone A, Pathak A, Grayson W Bone Res. 2025; 13(1):24.

PMID: 39984434 PMC: 11845787. DOI: 10.1038/s41413-025-00401-8.

Limb reduction in an Esco2 cohesinopathy mouse model is mediated by p53-dependent apoptosis and vascular disruption.

Strasser A, Gonzalez-Reiche A, Zhou X, Valdebenito-Maturana B, Ye X, Zhang B Nat Commun. 2024; 15(1):7154.

PMID: 39168984 PMC: 11339411. DOI: 10.1038/s41467-024-51328-3.

FGF signaling in cranial suture development and related diseases.

Zhao X, Erhardt S, Sung K, Wang J Front Cell Dev Biol. 2023; 11:1112890.

PMID: 37325554 PMC: 10267317. DOI: 10.3389/fcell.2023.1112890.

A novel pathogenic variant of associated with craniosynostosis: a case report of Heyn-Sproul-Jackson syndrome.

Kim G, Kim J, Lee J, Jang D Front Pediatr. 2023; 11:1165638.

PMID: 37303757 PMC: 10248406. DOI: 10.3389/fped.2023.1165638.

FGFR2 Mutation p.Cys342Arg Enhances Mitochondrial Metabolism-Mediated Osteogenesis via FGF/FGFR-AMPK-Erk1/2 Axis in Crouzon Syndrome.

Wang Y, Liu Y, Chen H, Liu X, Zhang Y, Wang Y Cells. 2022; 11(19).

PMID: 36231091 PMC: 9563077. DOI: 10.3390/cells11193129.

References

Merrill A, Bochukova E, Brugger S, Ishii M, Pilz D, Wall S . Cell mixing at a neural crest-mesoderm boundary and deficient ephrin-Eph signaling in the pathogenesis of craniosynostosis. Hum Mol Genet. 2006; 15(8):1319-28. DOI: 10.1093/hmg/ddl052. View

Yu H, Jerchow B, Sheu T, Liu B, Costantini F, Puzas J . The role of Axin2 in calvarial morphogenesis and craniosynostosis. Development. 2005; 132(8):1995-2005. PMC: 1828115. DOI: 10.1242/dev.01786. View

McBratney-Owen B, Iseki S, Bamforth S, Olsen B, Morriss-Kay G . Development and tissue origins of the mammalian cranial base. Dev Biol. 2008; 322(1):121-32. PMC: 2847450. DOI: 10.1016/j.ydbio.2008.07.016. View

Lemonnier J, Hay E, Delannoy P, Fromigue O, Lomri A, Modrowski D . Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1. Am J Pathol. 2001; 158(5):1833-42. PMC: 1891948. DOI: 10.1016/S0002-9440(10)64139-9. View

Ibrahimi O, Eliseenkova A, Plotnikov A, Yu K, Ornitz D, Mohammadi M . Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc Natl Acad Sci U S A. 2001; 98(13):7182-7. PMC: 34643. DOI: 10.1073/pnas.121183798. View

Orr-Urtreger A, Bedford M, Burakova T, Arman E, Zimmer Y, Yayon A . Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol. 1993; 158(2):475-86. DOI: 10.1006/dbio.1993.1205. View

Marie P . Fibroblast growth factor signaling controlling osteoblast differentiation. Gene. 2003; 316:23-32. DOI: 10.1016/s0378-1119(03)00748-0. View

Ornitz D, Itoh N . Fibroblast growth factors. Genome Biol. 2001; 2(3):REVIEWS3005. PMC: 138918. DOI: 10.1186/gb-2001-2-3-reviews3005. View

Iseki S, Wilkie A, Heath J, Ishimaru T, Eto K, Morriss-Kay G . Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development. 1997; 124(17):3375-84. DOI: 10.1242/dev.124.17.3375. View

10.

Richtsmeier J, Paik C, Elfert P, Cole 3rd T, Dahlman H . Precision, repeatability, and validation of the localization of cranial landmarks using computed tomography scans. Cleft Palate Craniofac J. 1995; 32(3):217-27. DOI: 10.1597/1545-1569_1995_032_0217_pravot_2.3.co_2. View

11.

Miki T, Bottaro D, Fleming T, Smith C, Burgess W, Chan A . Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci U S A. 1992; 89(1):246-50. PMC: 48213. DOI: 10.1073/pnas.89.1.246. View

12.

Wang Y, Xiao R, Yang F, Karim B, Iacovelli A, Cai J . Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouse. Development. 2005; 132(15):3537-48. DOI: 10.1242/dev.01914. View

13.

Kreiborg S, Cohen Jr M . The oral manifestations of Apert syndrome. J Craniofac Genet Dev Biol. 1992; 12(1):41-8. View

14.

Olsen B, Reginato A, Wang W . Bone development. Annu Rev Cell Dev Biol. 2000; 16:191-220. DOI: 10.1146/annurev.cellbio.16.1.191. View

15.

Dailey L, Ambrosetti D, Mansukhani A, Basilico C . Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev. 2005; 16(2):233-47. DOI: 10.1016/j.cytogfr.2005.01.007. View

16.

Wang X, Goh C, Li B . p38 mitogen-activated protein kinase regulates osteoblast differentiation through osterix. Endocrinology. 2006; 148(4):1629-37. DOI: 10.1210/en.2006-1000. View

17.

Marie P, Kaabeche K, Guenou H . Roles of FGFR2 and twist in human craniosynostosis: insights from genetic mutations in cranial osteoblasts. Front Oral Biol. 2008; 12:144-159. DOI: 10.1159/000115036. View

18.

El Ghouzzi V, Le Merrer M, Perrin-Schmitt F, Lajeunie E, Benit P, Renier D . Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet. 1997; 15(1):42-6. DOI: 10.1038/ng0197-42. View

19.

Iseki S, Wilkie A, Morriss-Kay G . Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development. 1999; 126(24):5611-20. DOI: 10.1242/dev.126.24.5611. View

20.

Baroni T, Carinci P, Lilli C, Bellucci C, Aisa M, Scapoli L . P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation. J Cell Physiol. 2004; 202(2):524-35. DOI: 10.1002/jcp.20148. View